Screener
Insulet PODD Drug Delivery — Total Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Insulet in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The source filing: Insulet’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001145197-26-000169
| (in millions) | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| U.S. | $544.1 | $453.2 | $1,059.7 | $854.9 |
| International | 251.8 | 185.8 | 494.6 | 338.1 |
| Total Omnipod products | 795.9 | 639.0 | 1,554.3 | 1,193.0 |
| Drug Delivery | 5.8 | 10.2 | 9.1 | 25.1 |
| Total revenue | $801.7 | $649.1 | $1,563.4 | $1,218.1 |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Insulet's drug delivery — total revenue?
- Insulet (PODD) reported drug delivery — total revenue of $5.8M in Q2 2026.
- How has Insulet's drug delivery — total revenue changed year-over-year?
- Insulet's drug delivery — total revenue decreased by 43.1% year-over-year, from $10.2M to $5.8M.
- What is the long-term trend for Insulet's drug delivery — total revenue?
- Over 4 years (2021 to 2025), Insulet's drug delivery — total revenue has grown at a -21.0% compound annual growth rate (CAGR), from $87.4M to $34.1M.
- What does drug delivery — total revenue mean?
- This metric represents the total net sales generated from the company's drug delivery segment, which focuses on providing specialized infusion technology for pharmaceutical partners. It captures the revenue derived from licensing, manufacturing, or supplying proprietary delivery systems to third-party pharmaceutical companies for use with their medications. This segment serves as a distinct revenue stream separate from the company's core consumer-facing diabetes management products.
Ask your AI about Insulet's drug delivery — total revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude